Revisiting Weight-Normalized SUV and Lean-Body-Mass-Normalized SUV in PET Studies
Affiliations
Affiliations
- Department of Nuclear Medicine, Faculty of Medicine, Kuwait University, and Mubarak Al-Kabeer Hospital, Jabriya, Kuwait isarikaya99@yahoo.com.
- Department of Community Medicine and Behavioral Sciences, Faculty of Medicine, Kuwait University, Safat, Kuwait; and.
- Department of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey.
Abstract
SUV normalized by total body weight is affected by the amount of body fat. The SUV of normal tissues and lesions is higher (overestimated) in obese patients than in patients with a normal body mass index (BMI). SUL (SUV normalized by lean body mass [LBM]) is recommended for more accurate SUV results. Given the importance of a quantitative PET parameter, particularly when comparing PET studies, we aimed to revisit the effect of obesity on SUV, measuring SUL in normal-BMI patients and obese patients and testing the effect of the amount of LBM. Methods: 18F-FDG whole-body images of adult patients were analyzed retrospectively. We measured both SUVmax and SUVmean in the blood pool and liver of patients with a normal BMI (18.5-24.9) and a high BMI (≥30) (obese). In all patients, we calculated LBM via an equation using patient height and weight and corrected all SUVs to SULs. Mean (±SD) SUVs and SULs were compared under various circumstances. Scatterplots were generated for weight and SUV-SUL differences. Results: SUVmean in the liver and blood pool was significantly higher in obese patients (30 patients) than in patients with a normal BMI (20 patients) (4.1 ± 0.7 and 3.0 ± 0.5, respectively, in liver, vs. 3.2 ± 0.6 and 2.4 ± 0.4, respectively, in blood pool; P < 0.001). SULmean was significantly lower in both liver and blood pool in all patients, being approximately 75% of SUVmean in patients with a normal BMI and 55% of SUVmean in obese patients (P < 0.001). SULmean in the liver and blood pool did not significantly differ between obese patients and normal-BMI patients (P > 0.05). The SUV-SUL difference was significantly higher in obese patients than in patients with a normal BMI (P < 0.001). These statistical results were the same when SUVmax and SULmax were compared. Conclusion: SUV overestimates metabolic activity in all patients, and this overestimation is more significant in obese patients than in patients with a normal BMI. SUL is not affected by body weight or the amount of LBM.
Keywords: PET; SUL; SUV; lean body mass; weight.
Similar articles
Riauka TA, Baracos VE, Reif R, Juengling FD, Robinson DM, Wieler M, McEwan AJB.Front Oncol. 2022 Jul 7;12:812777. doi: 10.3389/fonc.2022.812777. eCollection 2022.PMID: 35875083 Free PMC article.
Badawe EM, Abdel Gawad H, El-Nagdy MS, Khalil MM.Eur J Hybrid Imaging. 2022 Oct 13;6(1):22. doi: 10.1186/s41824-022-00142-5.PMID: 36224438 Free PMC article.
Is SUV Corrected for Lean Body Mass Superior to SUV of Body Weight in 68Ga-PSMA PET/CT?
Aksu A, Çapa Kaya G.Mol Imaging Radionucl Ther. 2021 Oct 15;30(3):144-149. doi: 10.4274/mirt.galenos.2021.59254.PMID: 34658229 Free PMC article.
Assessing PET Parameters in Oncologic 18F-FDG Studies.
Sarikaya I, Sarikaya A.J Nucl Med Technol. 2020 Sep;48(3):278-282. doi: 10.2967/jnmt.119.236109. Epub 2019 Dec 6.PMID: 31811061 Review.
Devriese J, Beels L, Maes A, Van De Wiele C, Gheysens O, Pottel H.Q J Nucl Med Mol Imaging. 2016 Mar;60(1):1-11. Epub 2015 Nov 17.PMID: 26576735 Review.
Cited by
Imaging assessment of toxicity related to immune checkpoint inhibitors.
Berz AM, Boughdad S, Vietti-Violi N, Digklia A, Dromain C, Dunet V, Duran R.Front Immunol. 2023 Feb 23;14:1133207. doi: 10.3389/fimmu.2023.1133207. eCollection 2023.PMID: 36911692 Free PMC article. Review.
Gherghe M, Mutuleanu MD, Stanciu AE, Irimescu I, Lazar AM, Toma RV, Trifanescu OG, Anghel RM.Cancers (Basel). 2023 Jan 23;15(3):696. doi: 10.3390/cancers15030696.PMID: 36765651 Free PMC article.
Gherghe M, Lazar AM, Simion L, Irimescu IN, Sterea MC, Mutuleanu MD, Anghel RM.Diagnostics (Basel). 2023 Jan 15;13(2):318. doi: 10.3390/diagnostics13020318.PMID: 36673128 Free PMC article.
Bang J, Park HL, Yoo IR, Shin HI, Kim GJ, Sun DI, Kim SY.Cancers (Basel). 2022 Dec 18;14(24):6242. doi: 10.3390/cancers14246242.PMID: 36551727 Free PMC article.
Whole-Body PET Imaging: A Catalyst for Whole-Person Research?
Sundar LKS, Hacker M, Beyer T.J Nucl Med. 2023 Feb;64(2):197-199. doi: 10.2967/jnumed.122.264555. Epub 2022 Dec 2.PMID: 36460342 No abstract available.